By Ama Sarfo ( December 3, 2012, 6:07 PM EST) -- A New Jersey federal judge on Friday refused to release documents from patent litigation over Pfizer's Neurontin to a class of plaintiffs accusing it of inhibiting the epilepsy treatment's generic rivals, saying their allegations weren't enough to overcome attorney-client privilege....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.